Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Monopar Therapeutics Inc. - Common Stock
(NQ:
MNPR
)
60.36
+2.76 (+4.79%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
335,126
Open
58.57
Bid (Size)
43.00 (100)
Ask (Size)
66.00 (300)
Prev. Close
57.60
Today's Range
58.25 - 61.03
52wk Range
26.05 - 105.00
Shares Outstanding
14,157,941
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Monopar Expands Leadership Team with Appointment of Seasoned Biopharma Executive Susan Rodriguez as Chief Commercial and Strategy Officer
March 02, 2026
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026
December 31, 2025
As the final bells ring on Wall Street for 2025, the biotechnology sector is celebrating a dramatic reversal of fortune. After years of navigating high interest rates and regulatory uncertainty, the...
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Economy
Performance
YTD
-8.6%
-8.6%
1 Month
+1.9%
+1.9%
3 Month
-19.6%
-19.6%
6 Month
+10.8%
+10.8%
1 Year
+102.9%
+102.9%
More News
Read More
This Home Depot Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
↗
November 14, 2025
Via
Benzinga
Monopar Therapeutics Reports Third Quarter 2025 Financial Results and Recent Developments
November 13, 2025
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Presents New Data and Analyses on Rapidly Improved Copper Balance in Wilson Disease Patients on Tiomolybdate Choline at AASLD - The Liver Meeting® 2025
November 09, 2025
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Announces Abstract Accepted for Oral Presentation at AASLD - The Liver Meeting® 2025
October 15, 2025
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
This Monopar Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
↗
October 13, 2025
Via
Benzinga
CrowdStrike To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Thursday
↗
September 25, 2025
Via
Benzinga
Monopar Therapeutics Inc. Announces Pricing of $135 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
September 23, 2025
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Announces Journal of Hepatology Publishes Physicians’ Letter to the Editor Demonstrating ALXN1840 Rapidly Improved Copper Balance in Wilson Disease Patients
September 23, 2025
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Why Monopar Therapeutics, A Top 1% Biotech Stock, Just Surged Into A Breakout
↗
September 15, 2025
Via
Investor's Business Daily
Monopar Announces Abstract Accepted with Distinction for Oral and Poster Presentations at the Upcoming American Neurological Association 2025 Annual Meeting
September 03, 2025
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar to Present New Long-Term Neurological Efficacy and Safety Data for ALXN1840 in Wilson Disease at the 150th American Neurological Association Annual Meeting
September 14, 2025
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Therapeutics Reports Second Quarter 2025 Financial Results and Recent Developments
August 12, 2025
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
This Hilton Worldwide Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
↗
June 23, 2025
Via
Benzinga
Monopar and EDNOC Announce Expanded Access Program for MNPR-101-Zr and MNPR-101-Lu in Advanced Cancers
June 11, 2025
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Therapeutics Announces Inclusion in the Russell 3000® and Russell 2000® Indexes
June 03, 2025
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Therapeutics Reports First Quarter 2025 Financial Results and Recent Developments
May 13, 2025
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Presents ALXN1840 Late-Breaker Data at EASL 2025
May 07, 2025
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Announces ALXN1840 Data Selected for Late-Breaker Presentation at EASL Congress 2025
April 29, 2025
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Developments
March 31, 2025
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
↗
March 21, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
December 20, 2024
Via
Benzinga
Monopar Therapeutics Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants
December 20, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Announces First Patient Dosed with its Novel Therapeutic Radiopharmaceutical MNPR-101-Lu
December 05, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Frequently Asked Questions
Is Monopar Therapeutics Inc. - Common Stock publicly traded?
Yes, Monopar Therapeutics Inc. - Common Stock is publicly traded.
What exchange does Monopar Therapeutics Inc. - Common Stock trade on?
Monopar Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Monopar Therapeutics Inc. - Common Stock?
The ticker symbol for Monopar Therapeutics Inc. - Common Stock is MNPR on the Nasdaq Stock Market
What is the current price of Monopar Therapeutics Inc. - Common Stock?
The current price of Monopar Therapeutics Inc. - Common Stock is 60.36
When was Monopar Therapeutics Inc. - Common Stock last traded?
The last trade of Monopar Therapeutics Inc. - Common Stock was at 03/13/26 04:00 PM ET
What is the market capitalization of Monopar Therapeutics Inc. - Common Stock?
The market capitalization of Monopar Therapeutics Inc. - Common Stock is 854.57M
How many shares of Monopar Therapeutics Inc. - Common Stock are outstanding?
Monopar Therapeutics Inc. - Common Stock has 855M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
